<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Melanin biosynthesis" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Melanin biosynthesis takes place in specialized cells called melanocytes, within membrane-bound organelles referred to as melanosomes. Melanosomes are transferred via dendrites to surrounding keratinocytes. Keratinocytes and melanocytes are collectively known as 'the epidermal melanin unit'. Each melanocyte is in contact with approximately 40 keratinocytes in the basal and suprabasal layers (Cichorek et al. 2013). Melanocytes are distributed in the epidermis, hair follicles, the inner ear and the eye (Yamaguchi et al. 2007, Tolleson 2005). &lt;br&gt;&lt;br&gt;Melanocytes in mammals and birds produce two chemically distinct types of melanin, black to brown eumelanin and yellow to reddish-brown pheomelanin (Ito &amp; Wakamatsu 2008, Simon et al. 2009, d'Ischia et al. 2013). These differ in their responses to UV radiation; eumelanin has the ability to convert absorbed light energy into heat energy (Meredith &amp; Riesz 2004) and to detoxify reactive oxygen species (ROS) (Bustamante et al. 1993), while pheomelanin is a phototoxic pro-oxidant (Samokhvalov 2005). Most natural melanin pigments contain eumelanin and pheomelanin (Ito &amp; Wakamatsu 2003) and are termed 'mixed' melanins. Neuromelanins are mixed melanin-like pigments which are mainly found in neurons of the substantia nigra and locus coeruleus (Fedorow et al. 2005). Synthesis of NM may prevent the accumulation of toxic catechol derivatives (Zecca et al. 2003). NM can sequester a variety of potentially damaging molecules such as beta-carbolines, heavy metal ions and 1-methyl-4-phenylpyridinium (MPP+) (D'Amato et al. 1986), a drug which causes Parkinson's Disease-like symptoms.  Models suggest that mixed melanogenesis occurs in three stages (Ito et al. 2000). The initial stage of melanin biosynthesis is the production of cysteinyldopas, which continues while sufficient cysteine is available. The second stage is the oxidation of cysteinyldopas to produce pheomelanin, which continues while cysteinyldopa concentration is sufficiently high. The last stage is the production of eumelanin, which begins when cysteinyldopas and cysteine are depleted. The ratio of eumelanin to pheomelanin is determined by tyrosinase activity and the availability of tyrosine and cysteine (Land et al. 2003).
 View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5662702 Reactome].</Comment>
  <Comment Source="Reactome-Converter">Pathway is converted from Reactome ID: 5662702</Comment>
  <Comment Source="Reactome-version">Reactome version: 88</Comment>
  <Comment Source="Reactome Author">Reactome Author: Jupe, Steve</Comment>
  <BiopaxRef>d11</BiopaxRef>
  <BiopaxRef>cc9</BiopaxRef>
  <Attribute Key="reactome_id" Value="5662702" />
  <Graphics BoardWidth="1519.0" BoardHeight="1337.0" />
  <DataNode TextLabel="L-Tyr" GraphId="e46b3" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="248.5" CenterY="185.0" Width="49.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:58315" />
  </DataNode>
  <DataNode TextLabel="hydroxyl" GraphId="d6db9" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="251.0" CenterY="267.0" Width="68.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29191" />
  </DataNode>
  <DataNode TextLabel="L-Dopaquinone" GraphId="ef567" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="390.5" CenterY="342.0" Width="109.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16852" />
  </DataNode>
  <DataNode TextLabel="H+" GraphId="bbefc" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="406.5" CenterY="193.0" Width="35.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:15378" />
  </DataNode>
  <DataNode TextLabel="TYR:2xCu2+" GraphId="da3e8" Type="Complex">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Graphics CenterX="201.0" CenterY="80.0" Width="84.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-5662696" />
  </DataNode>
  <DataNode TextLabel="TYR " GraphId="bc56f" Type="Protein" GroupRef="a855a">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Attribute Key="complex_id" Value="R-HSA-5662696" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="809.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P14679" />
  </DataNode>
  <DataNode TextLabel="Cu2+ " GraphId="f8e5d" Type="Metabolite" GroupRef="a855a">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Attribute Key="complex_id" Value="R-HSA-5662696" />
    <Attribute Key="copies_num" Value="2" />
    <Graphics CenterX="100.0" CenterY="829.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29036" />
  </DataNode>
  <DataNode TextLabel="O2" GraphId="cecd1" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="132.0" CenterY="447.0" Width="34.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:15379" />
  </DataNode>
  <DataNode TextLabel="L-Dopa" GraphId="ca926" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="684.0" CenterY="271.0" Width="62.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:57504" />
  </DataNode>
  <DataNode TextLabel="H2O" GraphId="a11a8" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="268.5" CenterY="450.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:15377" />
  </DataNode>
  <DataNode TextLabel="L-Cys" GraphId="c6693" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="469.0" CenterY="627.0" Width="52.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:35235" />
  </DataNode>
  <DataNode TextLabel="Cysteinyldopa&#xA;isomers" GraphId="f8dff" Type="Complex">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="670.5" CenterY="583.0" Width="97.0" Height="36.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-ALL-5662956" />
  </DataNode>
  <DataNode TextLabel="5-S-Cysteinyldopa " GraphId="b537a" Type="Metabolite" GroupRef="a860c">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662956" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="889.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:81392" />
  </DataNode>
  <DataNode TextLabel="2-S-Cysteinyl-DOPA " GraphId="e2856" Type="Metabolite" GroupRef="a860c">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662956" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="909.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:84296" />
  </DataNode>
  <DataNode TextLabel="2,5-S,S'-dicysteinyldopa " GraphId="e2a0e" Type="Metabolite" GroupRef="a860c">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662956" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="949.0" Width="100.0" Height="40.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:84298" />
  </DataNode>
  <DataNode TextLabel="BT, BTCA, BZ, ODHBT" GraphId="c9658" Type="Complex">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1002.0" CenterY="583.0" Width="94.0" Height="36.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-ALL-5662955" />
  </DataNode>
  <DataNode TextLabel="Benzothiazine " GraphId="d4676" Type="Metabolite" GroupRef="daa90">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662955" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1009.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:46899" />
  </DataNode>
  <DataNode TextLabel="7-(2-amino-2-carboxyethyl)-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid " GraphId="a0f39" Type="Metabolite" GroupRef="daa90">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662955" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1059.0" Width="100.0" Height="50.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:84301" />
  </DataNode>
  <DataNode TextLabel="benzothiazole " GraphId="f0efd" Type="Metabolite" GroupRef="daa90">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662955" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1079.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:84343" />
  </DataNode>
  <DataNode TextLabel="7-(2-amino-2-carboxyethyl)-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazin-3-one " GraphId="af959" Type="Metabolite" GroupRef="daa90">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662955" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1129.0" Width="100.0" Height="50.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:84344" />
  </DataNode>
  <DataNode TextLabel="pheomelanin" GraphId="d30b9">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1297.5" CenterY="581.0" Width="87.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="R-HSA-5665848" />
  </DataNode>
  <DataNode TextLabel="Dopachrome" GraphId="fc0f4" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="703.5" CenterY="177.0" Width="93.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:49108" />
  </DataNode>
  <DataNode TextLabel="DHICA" GraphId="e50f2" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="921.5" CenterY="177.0" Width="55.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16875" />
  </DataNode>
  <DataNode TextLabel="DCT:2xZn2+" GraphId="ea56f" Type="Complex">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Graphics CenterX="815.5" CenterY="77.0" Width="85.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-5662858" />
  </DataNode>
  <DataNode TextLabel="DCT " GraphId="fe806" Type="Protein" GroupRef="e400c">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Attribute Key="complex_id" Value="R-HSA-5662858" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1189.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P40126" />
  </DataNode>
  <DataNode TextLabel="Zn2+ " GraphId="f2101" Type="Metabolite" GroupRef="e400c">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Attribute Key="complex_id" Value="R-HSA-5662858" />
    <Attribute Key="copies_num" Value="2" />
    <Graphics CenterX="100.0" CenterY="1209.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29105" />
  </DataNode>
  <DataNode TextLabel="CO2" GraphId="cc72c" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="920.5" CenterY="292.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16526" />
  </DataNode>
  <DataNode TextLabel="DHI" GraphId="bb5bf" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="922.0" CenterY="229.0" Width="38.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:27404" />
  </DataNode>
  <DataNode TextLabel="DHI, DHICA" GraphId="fb50c" Type="Complex">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1038.0" CenterY="259.0" Width="76.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-ALL-5662708" />
  </DataNode>
  <DataNode TextLabel="DHI " GraphId="a9cac" Type="Metabolite" GroupRef="d2fea">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662708" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1269.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:27404" />
  </DataNode>
  <DataNode TextLabel="DHICA " GraphId="c0e81" Type="Metabolite" GroupRef="d2fea">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Attribute Key="complex_id" Value="R-ALL-5662708" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1289.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16875" />
  </DataNode>
  <DataNode TextLabel="Eumelanin" GraphId="d9c66">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1302.5" CenterY="318.0" Width="71.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Reactome" ID="R-HSA-5662678" />
  </DataNode>
  <DataNode TextLabel="Leucodopachrome" GraphId="c7c32" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="546.5" CenterY="177.0" Width="123.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:60872" />
  </DataNode>
  <DataNode TextLabel="L-Dopa" GraphId="ff613" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1024.0" CenterY="449.0" Width="62.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:57504" />
  </DataNode>
  <DataNode TextLabel="L-Dopa" GraphId="e0798" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="116.0" CenterY="362.0" Width="62.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:57504" />
  </DataNode>
  <DataNode TextLabel="OCA2" GraphId="fa993" Type="Protein">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Graphics CenterX="319.5" CenterY="84.0" Width="41.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q04671" />
  </DataNode>
  <DataNode TextLabel="SLC45A2" GraphId="ac1cd" Type="Protein">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Graphics CenterX="385.5" CenterY="83.0" Width="61.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q9UMX9" />
  </DataNode>
  <DataNode TextLabel="H2O" GraphId="c80d8" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1127.5" CenterY="111.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:15377" />
  </DataNode>
  <DataNode TextLabel="IQCA" GraphId="ac8ea" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="1123.5" CenterY="161.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:81394" />
  </DataNode>
  <DataNode TextLabel="TYRP1" GraphId="be24c" Type="Protein">
    <Attribute Key="cellular_location" Value="melanosome membrane" />
    <Graphics CenterX="1035.5" CenterY="83.0" Width="45.0" Height="22.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P17643" />
  </DataNode>
  <DataNode TextLabel="O2" GraphId="e6456" Type="Metabolite">
    <Attribute Key="cellular_location" Value="melanosome lumen" />
    <Graphics CenterX="948.0" CenterY="119.0" Width="34.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:15379" />
  </DataNode>
  <Interaction GraphId="add5d">
    <Comment Source="Reactome">Melanogenesis is initiated with the first step of tyrosine oxidation to dopaquinone, catalyzed by tyrosinase (Mason 1948, Hearing et al. 1980). This first step is the rate-limiting step in melanin synthesis; the remainder of the reaction sequence can proceed spontaneously at a physiological pH value (Halaban et al. 2002, Land et al. 2003).&lt;br&gt;&lt;br&gt;The melanocyte-specific transporter protein (OCA2, aka P protein, pink-eyed dilution protein homolog) is postulated to play a role in the processing and intracellular trafficking of tyrosinase (TYR) in the melanosome (Potterf et al. 1998, Toyofuku et al. 2002). It is a 110-kDa integral melanosomal protein with 12 predicted transmembrane domains, suggesting a transport function but its exact physiological role is still unknown. In humans, mutations in the OCA2 gene result in oculocutaneous albinism type 2, a disorder of pigmentation characterised by reduced biosynthesis of melanin in the skin, hair and eyes. This disorder is analogous to the pink-eyed dilution phenotype seen in mice with defective Oca2 (Toyofuku et al. 2002). A single SNP in the OCA2 gene is the major determinant of brown and/or blue eye colour (Sturm 2009).&lt;br&gt;&lt;br&gt;The membrane-associated transporter protein SLC45A2 (melanoma antigen AIM1, MATP) shows sequence and structural similarity to sucrose transport proteins yet its actual physiological substrate and role is still unclear. Mutations in SLC45A2 cause misrouting of tyrosinase similar to the cellular phenotype of OCA2 and cause oculocutaneous albinism type 4 (OCA4) (Cullinane et al. 2011).</Comment>
    <BiopaxRef>f57</BiopaxRef>
    <BiopaxRef>eb4</BiopaxRef>
    <BiopaxRef>a29</BiopaxRef>
    <BiopaxRef>c1b</BiopaxRef>
    <BiopaxRef>c4d</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="272.0" Y="224.0" />
      <Point X="358.0" Y="224.0" />
      <Anchor Position="0.0" Shape="None" GraphId="c16fc" />
      <Anchor Position="0.99" Shape="None" GraphId="b04ea" />
      <Anchor Position="0.5" Shape="None" GraphId="a5334" />
      <Anchor Position="0.5" Shape="None" GraphId="c6053" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="bf36a">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="248.0" Y="200.0" GraphRef="e46b3" RelX="-0.02040816326530612" RelY="1.0" />
      <Point X="272.0" Y="224.0" GraphRef="c16fc" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="e75e7">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="251.0" Y="252.0" GraphRef="d6db9" RelX="0.0" RelY="-1.0" />
      <Point X="272.0" Y="224.0" GraphRef="c16fc" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="f95cc">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="358.0" Y="224.0" GraphRef="b04ea" RelX="0.8600000000000136" RelY="0.0" />
      <Point X="390.0" Y="327.0" GraphRef="ef567" RelX="-0.009174311926605505" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="cae40">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="358.0" Y="224.0" GraphRef="b04ea" RelX="0.8600000000000136" RelY="0.0" />
      <Point X="389.0" Y="193.0" GraphRef="bbefc" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="a6fe4">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="243.0" Y="80.0" GraphRef="da3e8" RelX="1.0" RelY="0.0" />
      <Point X="319.0" Y="224.0" GraphRef="a5334" RelX="4.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="ebe26">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="355.0" Y="83.0" GraphRef="ac1cd" RelX="-1.0" RelY="0.0" />
      <Point X="319.0" Y="224.0" GraphRef="c6053" RelX="4.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="b93d5">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="355.0" Y="83.0" GraphRef="fa993" RelX="1.7317073170731707" RelY="-0.09090909090909091" />
      <Point X="319.0" Y="224.0" GraphRef="c6053" RelX="4.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662662" />
  </Interaction>
  <Interaction GraphId="e2168">
    <Comment Source="Reactome">Dopaquinone is highly reactive and in the absence of sulfhydryl compounds it undergoes the intramolecular addition of the amino group to produce an intermediate, leucodopachrome (also termed  cyclodopa). A redox exchange between cyclodopa and dopaquinone then gives rise to dopachrome, an orange-red intermediate (Raper 1927, Mason et al. 1948) and dopa. This latter reaction is considered the source of dopa formed during melanogenesis (Ito &amp; Wakamatsu 2008).</Comment>
    <BiopaxRef>a11</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="403.0" Y="324.0" />
      <Point X="531.0" Y="195.0" />
      <Anchor Position="0.0" Shape="None" GraphId="fbdd3" />
      <Anchor Position="0.99" Shape="None" GraphId="a2ab9" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662669" />
  </Interaction>
  <Interaction GraphId="add4a">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="390.0" Y="327.0" GraphRef="ef567" RelX="-0.009174311926605505" RelY="-1.0" />
      <Point X="403.0" Y="324.0" GraphRef="fbdd3" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662669" />
  </Interaction>
  <Interaction GraphId="c2aff">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="531.0" Y="195.0" GraphRef="a2ab9" RelX="1.2799999999999727" RelY="-1.2900000000000205" />
      <Point X="546.0" Y="192.0" GraphRef="c7c32" RelX="-0.008130081300813009" RelY="1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662669" />
  </Interaction>
  <Interaction GraphId="a4e19">
    <Comment Source="Reactome">Dopa is a substrate of tyrosinase, which can oxidize it  to dopaquinone (Young et al. 1974).</Comment>
    <BiopaxRef>bdd</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="163.0" Y="405.0" />
      <Point X="225.0" Y="405.0" />
      <Anchor Position="0.0" Shape="None" GraphId="b9a29" />
      <Anchor Position="0.99" Shape="None" GraphId="a19ac" />
      <Anchor Position="0.5" Shape="None" GraphId="b1b86" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="b8e32">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="132.0" Y="432.0" GraphRef="cecd1" RelX="0.0" RelY="-1.0" />
      <Point X="163.0" Y="405.0" GraphRef="b9a29" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="a44b3">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="147.0" Y="362.0" GraphRef="e0798" RelX="1.0" RelY="0.0" />
      <Point X="163.0" Y="405.0" GraphRef="b9a29" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="f3880">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="225.0" Y="405.0" GraphRef="a19ac" RelX="0.6200000000000045" RelY="0.0" />
      <Point X="247.0" Y="450.0" GraphRef="a11a8" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="e404b">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="225.0" Y="405.0" GraphRef="a19ac" RelX="0.6200000000000045" RelY="0.0" />
      <Point X="336.0" Y="342.0" GraphRef="ef567" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="ecb92">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="201.0" Y="91.0" GraphRef="da3e8" RelX="0.0" RelY="1.0" />
      <Point X="199.0" Y="405.0" GraphRef="b1b86" RelX="5.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662692" />
  </Interaction>
  <Interaction GraphId="cf46c">
    <Comment Source="Reactome">In the presence of sulfhydryl compounds such as cysteine, dopaquinone reacts to produce several cysteinyldopa (CD) isomers, 5-S-cysteinyldopa (5SCD) and 2-S-cysteinyldopa (2SCD) in 74% and 14% yields, respectively (Ito &amp; Prota 1977, Thompson et al. 1985). 2,5-S,S'-dicysteinyldopa (DiCD) is produced in a 5% yield. Further oxidation of the thiol adducts leads to the formation of pheomelanin via benzothiazine intermediates.</Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="495.0" Y="581.0" />
      <Point X="616.0" Y="581.0" />
      <Anchor Position="0.0" Shape="None" GraphId="e0cc1" />
      <Anchor Position="0.99" Shape="None" GraphId="c46e9" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662908" />
  </Interaction>
  <Interaction GraphId="be9f4">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="469.0" Y="612.0" GraphRef="c6693" RelX="0.0" RelY="-1.0" />
      <Point X="495.0" Y="581.0" GraphRef="e0cc1" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662908" />
  </Interaction>
  <Interaction GraphId="dae27">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="444.0" Y="342.0" GraphRef="ef567" RelX="0.981651376146789" RelY="0.0" />
      <Point X="495.0" Y="581.0" GraphRef="e0cc1" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662908" />
  </Interaction>
  <Interaction GraphId="d2962">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="616.0" Y="581.0" GraphRef="c46e9" RelX="1.2100000000000364" RelY="0.0" />
      <Point X="622.0" Y="583.0" GraphRef="f8dff" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662908" />
  </Interaction>
  <Interaction GraphId="a349f">
    <Comment Source="Reactome">Following the formation of cysteinyldopa (CD) isomers, pheomelanogenesis continues with the redox exchange of CD isomers with dopaquinone (DQ), generating cysteinyldopaquinone (CDQ). Once formed, CDQ rapidly cyclizes via attack of the cysteinyl side-chain amino group on the carbonyl group to produce a cyclic ortho-quinonimine intermediate (QI) (Napolitano et al. 1994, Land &amp; Riley 2000). Redox exchange between CD and QI leads to the production of a reduced form of QI, 3,4-dihydro-1,4-benzothiazine-3-carboxylic acid (DHBTCA) and CDQ (Napolitano et al. 2000, Wakamatsu et al. 2009). 

QI rapidly undergoes rearrangement, with or without decarboxylation, leading to 2H-1,4-benzothiazine (BT) and its 3-carboxy derivative, 2H-1,4-benzothiazine-3-carboxylic acid (BTCA) (Napolitano et al. 1994, 2008). The ratio of BT to BTCA depends on many factors including the pH of the medium and the presence or absence of metal ions (Di Donato et al. 2002, Napolitano et al. 2000). BT and BTCA are unstable, decaying in seconds. Modifications of the benzothiazine moiety of BT and BTCA lead to the formation of 3-oxo-3,4-dihydro-1,4-benzothiazine (ODHBT) and benzothiazole (BZ) (Napolitano et al. 1999, 2008). &lt;br&gt;&lt;br&gt;The reactions beyond BT and BTCA which ultimately lead to the production of pheomelanin appear to be very complex (Di Donato &amp; Napolitano 2003). Zn2+ promotes retention of the carboxyl group in BTCA while Fe3+ accelerates the ring contraction of BT to BZ (Di Donato et al. 2002). Production of ODHBT is increased by the presence of hydrogen peroxide (Di Donato et al. 2002).</Comment>
    <BiopaxRef>ba3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="766.0" Y="522.0" />
      <Point X="910.0" Y="522.0" />
      <Anchor Position="0.0" Shape="None" GraphId="d16f2" />
      <Anchor Position="0.99" Shape="None" GraphId="ffa6c" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662904" />
  </Interaction>
  <Interaction GraphId="df748">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="718.0" Y="583.0" GraphRef="f8dff" RelX="0.979381443298969" RelY="0.0" />
      <Point X="766.0" Y="522.0" GraphRef="d16f2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662904" />
  </Interaction>
  <Interaction GraphId="ffecf">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="444.0" Y="342.0" GraphRef="ef567" RelX="0.981651376146789" RelY="0.0" />
      <Point X="766.0" Y="522.0" GraphRef="d16f2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662904" />
  </Interaction>
  <Interaction GraphId="ff77b">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="910.0" Y="522.0" GraphRef="ffa6c" RelX="1.4400000000000546" RelY="0.0" />
      <Point X="955.0" Y="583.0" GraphRef="c9658" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662904" />
  </Interaction>
  <Interaction GraphId="a64a1">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="910.0" Y="522.0" GraphRef="ffa6c" RelX="1.4400000000000546" RelY="0.0" />
      <Point X="993.0" Y="449.0" GraphRef="ff613" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662904" />
  </Interaction>
  <Interaction GraphId="f99bd">
    <Comment Source="Reactome">The last stage of pheomelanogenesis is the oxidative polymerization of BT, BTCA, and the products of secondary modifications of the benzothiazine moieties of these to form pheomelanin. Several dimeric and trimeric intermediates have been identified (Napolitano et al. 2001) but it is unclear whether these are major components of natural pheomelanin pigments. Most studies have used powerful chemical oxidants (Di Donato et al. 2002, Napolitano et al. 2008). which may lead to a pheomelanogenesis process that differs from the in vivo process (Wakamatsu et al. 2008).</Comment>
    <BiopaxRef>db9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1055.0" Y="582.0" />
      <Point X="1251.0" Y="581.0" />
      <Anchor Position="0.0" Shape="None" GraphId="d94a7" />
      <Anchor Position="0.99" Shape="None" GraphId="de3b0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662891" />
  </Interaction>
  <Interaction GraphId="d7973">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1049.0" Y="583.0" GraphRef="c9658" RelX="1.0" RelY="0.0" />
      <Point X="1055.0" Y="582.0" GraphRef="d94a7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662891" />
  </Interaction>
  <Interaction GraphId="b3dde">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1251.0" Y="581.0" GraphRef="de3b0" RelX="1.9600000000000364" RelY="-0.009999999999990905" />
      <Point X="1254.0" Y="581.0" GraphRef="d30b9" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662891" />
  </Interaction>
  <Interaction GraphId="f606c">
    <Comment Source="Reactome">Dopachrome is converted to DHICA by DCT (Dopachrome tautomerase, Tyrosinase-related protein 2) (Tsukamoto et al. 1992, Kroumpouzos et al. 1994, Bouchard et al. 1994).</Comment>
    <BiopaxRef>bc9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="753.0" Y="176.0" />
      <Point X="891.0" Y="176.0" />
      <Anchor Position="0.0" Shape="None" GraphId="eb08d" />
      <Anchor Position="0.99" Shape="None" GraphId="d9539" />
      <Anchor Position="0.5" Shape="None" GraphId="f35bc" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662660" />
  </Interaction>
  <Interaction GraphId="fca32">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="749.0" Y="177.0" GraphRef="fc0f4" RelX="0.978494623655914" RelY="0.0" />
      <Point X="753.0" Y="176.0" GraphRef="eb08d" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662660" />
  </Interaction>
  <Interaction GraphId="f82f2">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="891.0" Y="176.0" GraphRef="d9539" RelX="1.3799999999999955" RelY="0.0" />
      <Point X="894.0" Y="177.0" GraphRef="e50f2" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662660" />
  </Interaction>
  <Interaction GraphId="e3689">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="773.0" Y="77.0" GraphRef="ea56f" RelX="-1.0" RelY="0.0" />
      <Point X="815.0" Y="175.0" GraphRef="f35bc" RelX="-7.0" RelY="-1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662660" />
  </Interaction>
  <Interaction GraphId="b27ad">
    <Comment Source="Reactome">Dopachrome spontaneously tautomerizes into 5,6-dihydroxyindole (DHI) via decarboxylation at physiological pH (Mason et al. 1948, Wakamatsu &amp; Ito 1988, Kishida et al. 2015). This is usually a minor process of melanin synthesis in vivo. However, in human hair follicular melanocytes, it predominates (Commo et al. 2012).</Comment>
    <BiopaxRef>a11</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="725.0" Y="195.0" />
      <Point X="856.0" Y="251.0" />
      <Anchor Position="0.0" Shape="None" GraphId="e9201" />
      <Anchor Position="0.99" Shape="None" GraphId="cdc17" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662706" />
  </Interaction>
  <Interaction GraphId="d9d40">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="703.0" Y="192.0" GraphRef="fc0f4" RelX="-0.010752688172043012" RelY="1.0" />
      <Point X="725.0" Y="195.0" GraphRef="e9201" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662706" />
  </Interaction>
  <Interaction GraphId="aecdc">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="856.0" Y="251.0" GraphRef="cdc17" RelX="1.3100000000000591" RelY="0.5600000000000023" />
      <Point X="899.0" Y="292.0" GraphRef="cc72c" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662706" />
  </Interaction>
  <Interaction GraphId="c27b5">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="856.0" Y="251.0" GraphRef="cdc17" RelX="1.3100000000000591" RelY="0.5600000000000023" />
      <Point X="903.0" Y="229.0" GraphRef="bb5bf" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5662706" />
  </Interaction>
  <Interaction GraphId="b2a94">
    <Comment Source="Reactome">Eumelanin is a stacked, aggregated oligomer, or heterogeneous polymer consisting of units representing different oxidative states of 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA), plus pyrrole units derived from their peroxidative cleavage (Meredith &amp; Sarna 2006, Ito &amp; Wakamatsu 2008). Eumelanin was thought to consist mostly of DHI but this was reconsidered when chemical degradation revealed that natural eumelanins include DHI and DHICA units in a nearly equal ratio (Ito 1986, d'Ischia et al. 2013). DHICA is produced by tautomerization of dopachrome.The oxidative polymerization of DHI can be catalyzed by Tyrosinase (TYR) (Tripathi et al. 1992) but may also be effectively catalysed by redox exchange with dopaquinone (Edge et al. 2006). Redox is likely to be less efficient for DHICA. In mice, the tyrosinase-related protein Tyrp1 can oxidize DHICA (Kobayashi et al. 1994) but human TYRP1 is unable to catalyze the same reaction (Boissy et al. 1998). Instead, human TYR oxidizes DHICA, DHI, tyrosine and dopa.</Comment>
    <BiopaxRef>e08</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1093.0" Y="318.0" />
      <Point X="1202.0" Y="318.0" />
      <Anchor Position="0.0" Shape="None" GraphId="c3314" />
      <Anchor Position="0.99" Shape="None" GraphId="fcc49" />
      <Anchor Position="0.5" Shape="None" GraphId="c2c22" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="bd2f9">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1076.0" Y="259.0" GraphRef="fb50c" RelX="1.0" RelY="0.0" />
      <Point X="1093.0" Y="318.0" GraphRef="c3314" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="e165d">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="444.0" Y="342.0" GraphRef="ef567" RelX="0.981651376146789" RelY="0.0" />
      <Point X="1093.0" Y="318.0" GraphRef="c3314" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="a7af9">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1202.0" Y="318.0" GraphRef="fcc49" RelX="1.0899999999999181" RelY="0.0" />
      <Point X="1267.0" Y="318.0" GraphRef="d9c66" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="cf7a8">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1202.0" Y="318.0" GraphRef="fcc49" RelX="1.0899999999999181" RelY="0.0" />
      <Point X="1055.0" Y="449.0" GraphRef="ff613" RelX="1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="e25a5">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="243.0" Y="80.0" GraphRef="da3e8" RelX="1.0" RelY="0.0" />
      <Point X="1155.0" Y="318.0" GraphRef="c2c22" RelX="7.5" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5663050" />
  </Interaction>
  <Interaction GraphId="ff14f">
    <Comment Source="Reactome">A redox exchange between leucodopachrome (cyclodopa) and dopaquinone gives rise to dopachrome, an orange-red intermediate (Raper 1927, Mason et al. 1948) and dopa. This reaction is considered the source of dopa formed during melanogenesis (Ito &amp; Wakamatsu 2008).</Comment>
    <BiopaxRef>a11</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="574.0" Y="224.0" />
      <Point X="645.0" Y="224.0" />
      <Anchor Position="0.0" Shape="None" GraphId="b8993" />
      <Anchor Position="0.99" Shape="None" GraphId="c1200" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5672019" />
  </Interaction>
  <Interaction GraphId="b8daa">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="546.0" Y="192.0" GraphRef="c7c32" RelX="-0.008130081300813009" RelY="1.0" />
      <Point X="574.0" Y="224.0" GraphRef="b8993" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5672019" />
  </Interaction>
  <Interaction GraphId="dd45a">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="444.0" Y="342.0" GraphRef="ef567" RelX="0.981651376146789" RelY="0.0" />
      <Point X="574.0" Y="224.0" GraphRef="b8993" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5672019" />
  </Interaction>
  <Interaction GraphId="f81df">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="645.0" Y="224.0" GraphRef="c1200" RelX="0.7100000000000364" RelY="0.0" />
      <Point X="653.0" Y="271.0" GraphRef="ca926" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5672019" />
  </Interaction>
  <Interaction GraphId="bf04f">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="645.0" Y="224.0" GraphRef="c1200" RelX="0.7100000000000364" RelY="0.0" />
      <Point X="657.0" Y="177.0" GraphRef="fc0f4" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-5672019" />
  </Interaction>
  <Interaction GraphId="a74fd">
    <Comment Source="Reactome">5,6-dihydroxyindole-2-carboxylic acid oxidase (TYRP1, aka gp75, CAS2, TRP-1) is an abundant protein in the melanosome membrane which, amongst other functions, can oxidise 5,6-dihydroxyindole-2-carboxylic acid (DHICA) into the corresponding 5,6-indolequinone-2-carboxylic acid (IQCA), thus promoting the incorporation of DHICA units into eumelanin (Olivares et al. 2001). Oculocutaneous albinism (OCA) is an autosomal recessive disorder caused by either complete lack of or a reduction of melanin biosynthesis in melanocytes. Mutations in TYRP1 cause OCA3, aka Rufous oculocutaneous albinism. Tyrosinase activity is normal and patients have only a moderate reduction of melanin. Darker-skinned sufferers have bright copper-red colouration of the skin and hair (Kamaraj &amp; Purohit 2014, Rooryck et al. 2006).</Comment>
    <BiopaxRef>d91</BiopaxRef>
    <BiopaxRef>b7f</BiopaxRef>
    <BiopaxRef>f8b</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1004.0" Y="131.0" />
      <Point X="1071.0" Y="131.0" />
      <Anchor Position="0.0" Shape="None" GraphId="bc924" />
      <Anchor Position="0.99" Shape="None" GraphId="ea569" />
      <Anchor Position="0.5" Shape="None" GraphId="bb400" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Interaction GraphId="f9100">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="948.0" Y="177.0" GraphRef="e50f2" RelX="0.9636363636363636" RelY="0.0" />
      <Point X="1004.0" Y="131.0" GraphRef="bc924" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Interaction GraphId="e3923">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="965.0" Y="119.0" GraphRef="e6456" RelX="1.0" RelY="0.0" />
      <Point X="1004.0" Y="131.0" GraphRef="bc924" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Interaction GraphId="f430d">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1071.0" Y="131.0" GraphRef="ea569" RelX="0.6700000000000728" RelY="0.0" />
      <Point X="1106.0" Y="111.0" GraphRef="c80d8" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Interaction GraphId="a8e4e">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1071.0" Y="131.0" GraphRef="ea569" RelX="0.6700000000000728" RelY="0.0" />
      <Point X="1102.0" Y="161.0" GraphRef="ac8ea" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Interaction GraphId="ee87d">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="1035.0" Y="94.0" GraphRef="be24c" RelX="-0.022222222222222223" RelY="1.0" />
      <Point X="1035.0" Y="131.0" GraphRef="bb400" RelX="-2.5" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-8878581" />
  </Interaction>
  <Label TextLabel="cytosol" GraphId="c5256" GroupRef="bfac5">
    <Graphics CenterX="66.0" CenterY="736.5" Width="64.0" Height="33.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Label TextLabel="melanosome lumen" GraphId="fc022" GroupRef="b9cd6">
    <Graphics CenterX="129.0" CenterY="679.5" Width="142.0" Height="33.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Shape GraphId="a05db" GroupRef="bfac5">
    <Graphics CenterX="747.5" CenterY="399.0" Width="1467.0" Height="764.0" ZOrder="16384" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="a516f" GroupRef="b9cd6">
    <Graphics CenterX="739.0" CenterY="397.0" Width="1394.0" Height="642.0" ZOrder="16384" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="a855a" GraphId="ee8a2" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-5662696" />
  </Group>
  <Group GroupId="a860c" GraphId="e3a48">
    <Attribute Key="complex_id" Value="R-ALL-5662956" />
  </Group>
  <Group GroupId="daa90" GraphId="d43e5">
    <Attribute Key="complex_id" Value="R-ALL-5662955" />
  </Group>
  <Group GroupId="e400c" GraphId="e0ce9" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-5662858" />
  </Group>
  <Group GroupId="d2fea" GraphId="afddc">
    <Attribute Key="complex_id" Value="R-ALL-5662708" />
  </Group>
  <Group GroupId="bfac5" GraphId="bcae9" Style="Group" />
  <Group GroupId="b9cd6" GraphId="b23aa" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d11">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18435614</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemistry of mixed melanogenesis--pivotal roles of dopaquinone.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ito S, Wakamatsu K.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23710556</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Melanins and melanogenesis: methods, standards, protocols.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">d'Ischia M, Wakamatsu K, Napolitano A, Briganti S, Garcia-Borron JC, Kovacs D, Meredith P, Pezzella A, Picardo M, Sarna T, Simon JD, Ito S.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f57">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6766744</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mammalin tyrosinase. Stoichiometry and measurement of reaction products.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hearing VJ, Ekel TM, Montague PM, Nicholson JM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9770375</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Potterf SB, Furumura M, Sviderskaya EV, Santis C, Bennett DC, Hearing VJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a29">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12028586</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Toyofuku K, Valencia JC, Kushimoto T, Costin GE, Virador VM, Vieira WD, Ferrans VJ, Hearing VJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19297406</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular genetics of human pigmentation diversity.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sturm RA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c4d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21677667</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cullinane AR, Vilboux T, O'Brien K, Curry JA, Maynard DM, Carlson-Donohoe H, Ciccone C, NISC Comparative Sequencing Program, Markello TC, Gunay-Aygun M, Huizing M, Gahl WA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a11">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18920770</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The chemistry of melanin; mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MASON HS.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bdd">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">4853153</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Melanin. I. Kinetics of the oxidative cyclization of dopa to dopachrome.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Young TE, Griswold JR, Hulbert MH.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10952395</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Spontaneous redox reactions of dopaquinone and the balance between the eumelanic and phaeomelanic pathways.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Land EJ, Riley PA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19493317</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wakamatsu K, Ohtara K, Ito S.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8048919</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Functional analysis of the slaty gene product (TRP2) as dopachrome tautomerase and the effect of a point mutation on its catalytic function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kroumpouzos G, Urabe K, Kobayashi T, Sakai C, Hearing VJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e08">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17083485</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The physical and chemical properties of eumelanin.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meredith P, Sarna T.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d91">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11171088</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Olivares C, Jiménez-Cervantes C, Lozano JA, Solano F, García-Borrón JC.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b7f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25093188</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mutational analysis of oculocutaneous albinism: a compact review.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kamaraj B, Purohit R.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16704458</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rooryck C, Roudaut C, Robine E, Müsebeck J, Arveiler B.</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>

